newsgathers

Significant Investor Activity in Pfizer Options

A notable surge in bearish options trading for Pfizer (PFE) has been detected by Benzinga's options scanner, indicating that influential investors are taking a cautious stance. While some investors remain bullish, a significant portion is leaning bearish, with a considerable amount invested in put options. This activity suggests potential price movements for Pfizer within a target range of $18.0 to $28.0 over the next three months, prompting a closer look at the company's market performance and expert opinions.